Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2003
04/23/2003EP1303495A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303188A2 Herbicidal agent
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0801062B1 Pyrimidine derivatives
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003CN1413198A Methods and compositions utilizing quianzolinones
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1106391C Magnolol series compounds and synthesizing process thereof, and medicinal composition using same as active component
04/23/2003CN1106371C Liquid crystal compounds having perfluoroether terminal portions
04/22/2003US6552193 Chloropyrimidine intermediates
04/22/2003US6552028 Inhibiting the binding of eotaxin to chemokine-3 (ccr-3) receptor; antiasthmatics
04/22/2003US6552027 4-((3-hydroxyphenyl)amino),6,7-dimethoxy-quinazoline for example; conjugates with epidermal growth factor
04/17/2003WO2003031606A2 Crystal structure of an aurora kinase catalytic domain, and use thereof
04/17/2003WO2003031458A1 Methods for synthesis of diarylmethanes
04/17/2003WO2003031406A2 Kinase inhibitor scaffolds and methods for their preparation
04/17/2003WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
04/17/2003WO2003006454A3 Heterocyclic carboxamides and their use as fungicides
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003WO1999043212A3 Wood preservatives
04/17/2003US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents
04/17/2003US20030073725 Naphtalene derivatives and their pharmaceutical use
04/17/2003US20030073710 Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073641 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
04/17/2003US20030073047 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent
04/17/2003CA2463563A1 Kinase inhibitor scaffolds and methods for their preparation
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1302458A1 Ester derivatives
04/16/2003EP1301491A1 Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
04/16/2003EP1301490A2 5-substituted 2-aryl-4-pyrimidinones
04/16/2003EP1301489A2 Synthesis of chlorinated pyrimidines
04/16/2003EP1301466A2 7-substituted tetracycline compounds
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1051404B1 Substituted phenyluracils with herbicidal effect
04/16/2003EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/16/2003EP0880508B1 Quinazoline derivatives as vegf inhibitors
04/16/2003CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/16/2003CN1410418A Derivative containing alkyl sulfanyl hydrazone having insecticidal, antibacterial and herbicidal activity and its preparation method
04/16/2003CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient
04/16/2003CN1105712C N-cyanoaryl nitrogen heterocyclic compound
04/16/2003CN1105711C 嘧啶衍生物 Pyrimidine derivatives
04/16/2003CN1105710C Substituted diazacyclo hexandi (thi) ones
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/15/2003US6548513 (E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(methyl -sulfonyl)amino)pyrimidin-5-yl)-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or salt, stabilized by an inorganic salt having a multivalent cation, excluding synthetic hydrotalcite
04/15/2003US6548511 Insecticidal/acaricidal agents
04/15/2003US6548507 Use of sodium channel antagonists in the treatment of diseases mediated or exacerbated by neuronal apoptosis, such as multiple sclerosis; administering drugs such as lamotrigine
04/15/2003US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives
04/15/2003US6548486 New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid
04/15/2003US6548449 Substituted phenyluracils with herbicidal effect
04/15/2003US6546929 Dry powder dispersing apparatus and methods for their use
04/15/2003CA2097715C Indan derivatives
04/15/2003CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors
04/11/2003WO2002034724A1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses
04/10/2003WO2003029226A1 Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides
04/10/2003WO2003029225A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
04/10/2003WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/10/2003WO2003028641A2 Mch receptor antagonists
04/10/2003WO2003028463A1 Herbicide composition
04/10/2003WO2003000186A3 Novel phenylamino-pyrimidines and uses thereof
04/10/2003WO2002102793A3 Quinazolinediones as antibacterial agents
04/10/2003WO2002078639A3 A method of treating proliferative diseases using eg5 inhibitors
04/10/2003WO2002059083A3 Novel compounds
04/10/2003US20030069425 Substituted pyrimidine compounds and methods of use
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069267 Modulators of protein tyrosine phosphatases (PTPases)
04/10/2003US20030069248 Antiinflammatory agents; controlling cell cycle
04/10/2003US20030069239 Anticancer agents
04/10/2003US20030069234 CXCR3 antagonists
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2461976A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
04/10/2003CA2460594A1 Mch receptor antagonists
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/09/2003EP1299390A1 Novel triazolo pyrimidine compounds
04/09/2003EP1299389A1 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
04/09/2003EP1299363A1 Polymorphic forms/hydrates of n- 4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1017681B1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates
04/09/2003EP0842155B1 Substituted aminouracils
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003CN1105116C Thienopyrimidine with PDE V-inhibiting effect
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105113C Fungicidal pyrimidinones
04/09/2003CN1105110C Process for preparing 4,6-dihydroxypgrimidine
04/09/2003CN1105109C Chloropyrimide intermediates
04/09/2003CN1105108C Process for preparation of phenoxy pyrimidine compounds
04/08/2003US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them